Key Takeaway: Johnson & Johnson is set to participate in the Goldman Sachs 47th Annual Global Healthcare Conference. This event highlights the company's ongoing engagement with investors and stakeholders in the healthcare sector. Further details about the conference and J&J's specific agenda have not been disclosed.
Price reaction · baseline $221.32 (2026-05-08 close) · 3 other JNJ headline(s) in the window, move may be shared
day 0 close · peak
0%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2
Full Press Release Details
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 47thAnnual Global Healthcare Conference on Tuesday, June 9th, 2026. Management will participate in a Fireside Chat at 10:00 a.m. Eastern Time.
This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website atwww.investor.jnj.com.
The audio webcast replay will be available approximately 48 hours after the webcast.